Joseph Kim serves as a senior advisor of clinical innovation at Eli Lilly, focusing on developing and implementing innovative patient engagement solutions. He has spent over 18 years in the pharma industry utilizing a unique approach that integrates his experiences working for sponsors, CROs and technology vendors. He has a robust combination of experience that includes early and late phase clinical research and a well-known history of innovation in the clinical research industry. He has been recognized as one of Top 100 individuals on the 2015 MedicineMakers Power List, and 20 Innovators Changing the Face of the Clinical Trials Industry by CenterWatch in 2013.
Kim holds a bachelor’s in molecular biology from Lehigh University and an MBA from Villanova.